Clinical trial
Trial of Rituximab Given Pre-Transplant to Sensitised Live Donor Kidney…
NCT00371904 · Hunter and New England Health, Other · Unknown status
Key facts
| NCT number | NCT00371904 |
|---|---|
| Title | Trial of Rituximab Given Pre-Transplant to Sensitised Live Donor Kidney Recipients |
| Official title | A Prospective Open Label Randomised Multicentre Study Evaluating the Efficacy & Safety of Rituximab Given Pre-Transplant to Sensitised Renal Allograft Recipients in Addition to a "Standard" Desensitisation Regimen Consisting of PE/IVIG & MMF |
| Acronym | RAPTURE |
| Lead sponsor | Hunter and New England Health, Other |
| Collaborators | Melbourne Health Princess Alexandra Hospital, Brisbane, Australia Royal Prince Alfred Hospital, Sydney, Australia Auckland City Hospital Monash Medical Centre Royal Perth Hospital Westmead Hospital… |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Transplantation |
| Intervention type | Drug |
| Interventions | Rituximab, Standard Care |
| Enrollment | 192 |
| Start date | Apr 1, 2006 |
| Completion | Jan 1, 2009 |
| First posted | Sep 4, 2006 |
| Last update posted | May 21, 2008 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: